HIV Lipodystrophy in Participants Randomised to Lopinavir/Ritonavir (LPV/r) +2–3 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) or LPV/r + Raltegravir as Second-Line Antiretroviral Therapy
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Public Library of Science
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813715/ |
| id |
pubmed-3813715 |
|---|---|
| recordtype |
oai_dc |
| spelling |
pubmed-38137152013-11-07 HIV Lipodystrophy in Participants Randomised to Lopinavir/Ritonavir (LPV/r) +2–3 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) or LPV/r + Raltegravir as Second-Line Antiretroviral Therapy Martin, Allison Moore, Cecilia L. Mallon, Patrick W. G. Hoy, Jennifer F. Emery, Sean Belloso, Waldo H. Phanuphak, Praphan Ferret, Samuel Cooper, David A. Boyd, Mark A. Research Article Public Library of Science 2013-10-30 /pmc/articles/PMC3813715/ /pubmed/24204757 http://dx.doi.org/10.1371/journal.pone.0077138 Text en © 2013 Martin et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
| repository_type |
Open Access Journal |
| institution_category |
Foreign Institution |
| institution |
US National Center for Biotechnology Information |
| building |
NCBI PubMed |
| collection |
Online Access |
| language |
English |
| format |
Online |
| author |
Martin, Allison Moore, Cecilia L. Mallon, Patrick W. G. Hoy, Jennifer F. Emery, Sean Belloso, Waldo H. Phanuphak, Praphan Ferret, Samuel Cooper, David A. Boyd, Mark A. |
| spellingShingle |
Martin, Allison Moore, Cecilia L. Mallon, Patrick W. G. Hoy, Jennifer F. Emery, Sean Belloso, Waldo H. Phanuphak, Praphan Ferret, Samuel Cooper, David A. Boyd, Mark A. HIV Lipodystrophy in Participants Randomised to Lopinavir/Ritonavir (LPV/r) +2–3 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) or LPV/r + Raltegravir as Second-Line Antiretroviral Therapy |
| author_facet |
Martin, Allison Moore, Cecilia L. Mallon, Patrick W. G. Hoy, Jennifer F. Emery, Sean Belloso, Waldo H. Phanuphak, Praphan Ferret, Samuel Cooper, David A. Boyd, Mark A. |
| author_sort |
Martin, Allison |
| title |
HIV Lipodystrophy in Participants Randomised to Lopinavir/Ritonavir (LPV/r) +2–3 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) or LPV/r + Raltegravir as Second-Line Antiretroviral Therapy |
| title_short |
HIV Lipodystrophy in Participants Randomised to Lopinavir/Ritonavir (LPV/r) +2–3 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) or LPV/r + Raltegravir as Second-Line Antiretroviral Therapy |
| title_full |
HIV Lipodystrophy in Participants Randomised to Lopinavir/Ritonavir (LPV/r) +2–3 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) or LPV/r + Raltegravir as Second-Line Antiretroviral Therapy |
| title_fullStr |
HIV Lipodystrophy in Participants Randomised to Lopinavir/Ritonavir (LPV/r) +2–3 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) or LPV/r + Raltegravir as Second-Line Antiretroviral Therapy |
| title_full_unstemmed |
HIV Lipodystrophy in Participants Randomised to Lopinavir/Ritonavir (LPV/r) +2–3 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) or LPV/r + Raltegravir as Second-Line Antiretroviral Therapy |
| title_sort |
hiv lipodystrophy in participants randomised to lopinavir/ritonavir (lpv/r) +2–3 nucleoside/nucleotide reverse transcriptase inhibitors (n(t)rti) or lpv/r + raltegravir as second-line antiretroviral therapy |
| description |
|
| publisher |
Public Library of Science |
| publishDate |
2013 |
| url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813715/ |
| _version_ |
1612022144216072192 |